Effect of Thaw Temperature on Murine Blastocyst Development
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Assisted Reproductive Technology (ART) methods are employed to help infertile couples conceive. One such ART procedure is
in vitro fertilization (IVF) and embryo culture (EC). During IVF-EC, supernumerary embryos are often produced and
cryopreserved for future use. Embryos frozen and thawed have reduced rates of blastocyst development. Thawing temperature is
one of the factors thought to affect embryo development after cryopreservation. The objective of this study was to determine if
varying thaw temperatures affect embryo development. Using a randomized, controlled study, approximately 230 two-cell
murine embryos were exposed to cryoprotectants and cryopreserved in lots of 15 embryos per straw. A total of 16 straws were
cryopreserved. Cryopreserved embryos were thawed in water baths set at either 30°C (n = eight straws) or 37°C (n = eight
straws). Once the straws were thawed and the cryoprotectant removed, the embryos were incubated for 72 hours and assessed for
blastocyst development. Proportions between blastocyst developments were analyzed using the Chi square test. Blastocyst
development for straws thawed at 30°C was 52.1% (63/121) compared to 45.5% (50/110) for straws thawed at 37°C. These
values were not significantly different (P = 0.4). In conclusion, the range of thaw temperature used for this study had no effect
on post-thaw embryo development. Future studies should assess other aspects of the thawing procedure, including length of time
straws remain in the water bath, as well as the effect of pre-thawing straws at room temperature before placing them in the water
bath.

Introduction
For three decades, Assisted Reproductive
Technology (ART) has been helping infertile couples
conceive. Since the birth of the first “test-tube baby” in
1978, reproductive technology has made many advances in
its ability to overcome infertility (Sher et al., 2005).
Couples are classified “infertile” if they have not used
contraception for a year or more and have not conceived.
In 2004, nearly 50,000 infants were born in the United
States to “infertile” couples because of ART (Centers for
Disease Control and Prevention, 2006).
An in vitro fertilization (IVF) and embryo culture
(EC) cycle begins when a woman starts taking fertility
drugs or has her ovaries monitored for follicular
development (Wright et al., 2004; Centers for Disease
Control and Prevention, 2006). The next step is eggretrieval, after which the eggs (oocytes) are combined with
sperm in the laboratory. The subsequent embryos are
evaluated morphologically and two to three of the “best”
embryos are transferred to the patient. If the transfer is
successful and implantation occurs, the cycle is deemed a
clinical pregnancy. The last step, and ultimate goal, is a
live-birth delivery, defined as a birth resulting in one or
more live born neonates (American Society for
Reproductive Medicine, 2004). The Center for Disease
Control and Prevention reported that of the 127,977 IVFEC cycles initiated in 2004, 36,760 (28.7%) resulted in
live-birth deliveries.
In many cases, infertile women have to undergo
multiple cycles before pregnancy is established, and even
more cycles before a live-birth is obtained. Often times,
with more cycles initiated comes an increase in number of

embryos placed back into the uterus. This increased
number of embryos transferred often translates into a
multiple pregnancy. Unfortunately, multiple pregnancy
often leads to serious consequences, especially if the
pregnancy results in triplet births or greater. Therefore,
multiple-infant pregnancies should be considered a
complication of ART, as they are associated with a number
of problems including higher rates of caesarean section,
prematurity, low birth weight, and infant disability or
death. Nearly one-third of pregnancies resulting from ART
conclude in multiple-infant live births.
Distributing the embryos obtained during the
course of one IVF-EC cycle over a number of cycles is a
beneficial alternative to undergoing fresh retrievals each
time (Edgar et al., 2000). Cryopreserving the embryos
from the first cycle and using them for later cycles fully
uses the potential of the first oocyte retrieval, while
allowing all the embryos resulting from that cycle to be
used rather than discarded (Jones et al., 1997; Schnorr et
al., 2000; Edgar et al., 2005). Cryopreserving also provides
a useful tool for avoiding multiple-infant pregnancies.
Instead of transferring numerous embryos in the first
transfer, some may be stored for another transfer, thus
reducing the risk of multiple infants (Oehninger et al.,
2000; Cohen et al., 2001) and increasing the probability of
obtaining a pregnancy with one ART cycle (Jones et al.,
1997).
Another complication with the IVF-EC cycle is
ovarian hyperstimulation syndrome (OHSS), and occurs in
an estimated 1% to 10% of ART cases when the ovaries are
stimulated for ovulation induction (Fasouliotis and
Schenker, 2005). In extreme cases, OHSS can cause severe
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morbidity and even death. If the woman fails to conceive,
the symptoms disappear rapidly; however, if a pregnancy is
obtained, the symptoms may become progressively worse
(Sher et al., 2005). According to Chung et al. (2006) and
Edgar et al. (2005), OHSS is a greater risk in multipleinfant pregnancies and because of this, it is recommended
that patients with severe OHSS undergo oocyte collection,
cryopreserve of their embryos, and end the cycle,
postponing embryo transfer until later.
These complications associated with the ART
process (the need for numerous cycles to obtain a
pregnancy, multiple-infant pregnancies, and the risks of
OHSS) have been decreased by the growing use of
cryopreservation in ART laboratories (Edgar et al., 2000;
Oehninger et al., 2000; Schnorr et al., 2000; Edgar et al.,
2005).
Cryopreservation is the preservation of cells,
tissues, organs, or embryos by freezing. Since the early
1980’s, ART has utilized this technology as a means to
store embryos for future use (Trounson and Mohr, 1983).
The implementation of cryopreservation has given ART
clinics the freedom to use fewer embryos for transfer, as
they are able to store the supernumerary embryos and use
them later if pregnancy is not established (Edgar et al.,
2005). Freezing provides an alternative for patients who
may not wish to discard unused embryos, but who are also
wary of a multiple-infant pregnancy and so do not wish to
transfer all the embryos at once.
Even though cryopreservation is advantageous
for patients, it has its own drawbacks. The 2005 National
Summary of ART clinics in the United States reported that
the percentage of transfers resulting in live births from
fresh embryos in women under 35 years of age was about
43%, while only 32% of thawed embryos resulted in live
births (Society for Assisted Reproductive Technology,
2006). However, some believe that the strict criteria used
to choose fresh embryos for transfer gives an advantage to
those embryos and, consequently, a disadvantage to those
embryos left for cryopreservation (Edgar et al., 2000).
Edgar et al. (2000) found that nearly 45% of
thawed embryos suffered some amount of blastomere (cell)
loss, causing an approximate 30% reduction in
implantation. They also suggested from these data that
80% of the resulting implantations arise from thawed
embryos, which suffered no blastomere loss. Therefore, if
methods can be altered in such a way as to protect the
blastomeres from damage during cryopreservation/
thawing, the patient should have an improved chance for
implantation with the thawed embryos.
The purpose of this study was to determine if
varying the temperatures at which cryopreserved embryos
are thawed affects the rate of post-thaw blastocyst
development.

Materials and Methods
Animals
The complete cryopreservation procedure for
mouse embryos has been described earlier (Boone et al,
2004). Specific pathogen-free mice (B6C3F1) were
obtained from Jackson Labs.
Female mice were
superovulated with intraperitoneal injection of 5.0
International Units (IU) of pregnant mare’s serum
gonadotropin (PMSG; Calbiochem, San Diego, CA). Each
female was injected intraperitoneally with 5.0 IU human
chorionic gonadotropin (hCG; Sigma Aldrich, St. Louis,
MO) 48 hours after PMSG injection and immediately
placed with a male. Females were sacrificed approximately
43 hours after hCG injection. Embryos were collected via
oviductal lavage using approximately 0.1 mL of
Dulbecco’s
phosphate-buffered
saline.
Only
morphologically normal two-cell embryos were used in the
study. All of these procedures complied with an approved
Animal Research Committee protocol.
Cryopreservation
Embryos were cryopreserved in 1.5M
propanediol and 0.1M Sucrose (SAGE In-Vitro
Fertilization, Inc., Trumbull, CT), and subsequently frozen
at the two-cell stage of development using the Sage
Embryo Freeze protocol. Embryos were moved through
three increasing levels of cryoprotectant to help remove
water from the cells. Fifteen embryos were loaded into a
plastic straw and heat sealed. A total of 16 straws were
used in this experiment. Next, the straws were placed in a
programmable freezer (Planer Freezer, Planer Co., UK) and
cooled using the following settings: Ramp 1) 23°C to -6°C
at minus 2°C per minute; Ramp 2) held at -6°C for 15
minutes for seeding (seeded 5 minutes into the ramp with
10 minutes post-seeding soak); Ramp 3) -6°C to -35°C at
minus 0.3°C per minute; Ramp 4) held for 5 minutes;
Ramp 5) -35°C to -180°C at minus 50°C per minute; and
Ramp 6) held at -180°C for 5 minutes. The straws then
were removed from the freezing chamber and plunged into
liquid nitrogen for storage.
Thaw Procedure
Cryopreserved straws were thawed individually.
Each was removed from the liquid nitrogen tank and
allowed to thaw for 30 seconds at room temperature. The
straw then was placed in a water bath for 30 seconds. Eight
straws were thawed in water baths set at 30°C, and eight
straws were thawed in water baths set at 37°C.
Cryoprotectant was removed by exposing the embryos to
decreasing concentrations of cryoprotectant (Quinn’s
Advantage Thaw Kit, SAGE In-Vitro Fertilization, Inc.,
Trumbull, CT). Upon removal of the cryoprotectants, the
embryos were incubated for 72 hours and assessed for
blastocyst development based on morphology.
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Statistics
Proportions between blastocyst development for
the embryos in the two different thaw temperatures were
analyzed using the Chi square test.

Results

A

Blastocyst development for straws thawed at
30°C was 52.1% (63/121), compared with 45.5% (50/110)
for straws thawed at 37°C. These two developmental rates
were not statistically different (P = 0.4). Data are depicted
in Table 1.
Figure 1 shows four embryos thawed in the
course of this study.
Embryo A is a blastocyst,
characterized by the intact zona pellucida. Embryo B is an
early blastocyst that has an extruded degenerated
blastomere. Embryo C is a morula containing degenerated
blastomeres. Embryo D is a degenerated four-cell embryo.
This figure represents the type of embryos observed in this
project. For our data, two of these embryos were classified
as blastocysts and two as non-blastocysts.

Thaw

Non-

Temperature

blastocyst

(°C)

(%)

Blastocyst

P value

(%)

47.9

52.1

(58/121)

(63/121)

30
0.4
54.5

45.5

(60/110)

(50/110)

37

Table 1. Percent of post-thaw mouse blastocyst development after
thawing in different temperatures.

Discussion
Cryopreservation has been a useful tool for
infertile couples undergoing IVF-EC. However, thawed
embryos have reduced rates of blastocyst development
which adversely affects birth rates. The objective of this
study was to assess the effect of different thaw
temperatures on post-thaw blastocyst development.
Thaw procedures reported in other studies differ
considerably. Valojerdi et al. (2002) reported thawing twocell mouse embryos for 10 seconds at room temperature
before shaking them in a 20°C water bath for 20 seconds
and subsequently passing them through a series of dilution
and rehydration steps. Another study reported thawing the

C

D

Figure 1. Development of four murine embryos 72 hours postthaw.

vials in which the embryos were stored in a water bath at
31°C for 3 minutes before moving the embryos through a
series of dilutions to remove the cryoprotectants (Burns et
al., 1999). These two examples demonstrate how diverse
the procedures are for thawing cryopreserved embryos,
with a time difference of over two-and-one-half minutes
and a temperature difference of 11°C.
For our study, murine embryos were
cryopreserved and sequentially thawed in water baths at
30°C or 37°C for 30 seconds. Our results determined no
significant difference in post-thaw murine blastocyst
development between embryos thawed at 30°C and those
thawed at 37°C. This may provide evidence to suggest that
slightly varying thaw temperatures are inconsequential to
the development of post-thaw blastocysts. However, many
other aspects of the cryopreservation process should be
assessed to determine their roles in affecting thawedembryo development. For example, just as the time and
temperature of reported thaw procedures varied, so do the
dilution and rehydration steps. Perhaps if more accurate
and precise methods can be developed for thawing
cryopreserved embryos, subsequent thawed-embryo
development rates, and ultimately birth rates, can be
improved.
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